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Radiation Epidemiology: Old and New
Challenges
by Roy E. Shore*
Overthe last 40 years the amount ofknowledge about human radiation effects has increaseddramatically.
During that interval, radiation epidemiologists have documented a number ofadditional types ofradiation-
induced cancerand have establishedrough estimates ofthe magnitudeofcancerrisks. Nevertheless, we cur-
rently have inadequate knowledge about a number of factors that help define the magnitude of radiation
risks. These include questions ofestimating risk over the lifetime, shapes ofthe dose-effect curves, magni-
tude ofrisks at low doses, potentiation between radiation and other agents, and the nature and role ofhost
susceptibility factors. Data from various studies are used to illustrate these questions.
In the four decades since the New York University In-
stitute of Environmental Medicine was founded, the
knowledge base ofradiation epidemiology has expanded
greatly. Forty years ago there were indications that radi-
ation causedbone cancer, leukemia, andlungcancer. That
it also caused breast cancer, thyroid cancer, stomach and
colon cancer, multiple myeloma, and many other types of
cancer was yet to be learned. Thus, for several decades
radiation epidemiology consisted mainly offinding new
cancer sites for which radiation was a causal agent and
makinggross estimates ofthe amount ofcancer induction
at those cancer sites based on populations with high
levels ofradiation exposure. The data came chiefly from
the Japanese atomic bomb study, series ofpatients who
had hadradiation treatment for avariety ofmedical con-
ditions, and workers in mines with high radon levels.
The NYU Institute ofEnvironmental Medicine began
to play a role in radiation epidemiology about 25 years
ago. A study of patients treated with X-rays for ring-
worm ofthe scalp during childhood was begun and has
continued with intermittent follow-ups to thepresent. At
that time there was some indication from case reports
and clinical series(1)thatlarge doses ofX-rays to the thy-
roid gland caused thyroid cancer, but this study was
among the first to show that low doses ofradiation also
caused thyroid tumors and that brain tumors were
caused by radiation (2,3). Perhaps the most important
contribution ofthe study was to bring data to the atten-
tion ofthe radiation protection communityindicatingthat
skin cancers could be caused by low to moderate doses
ofX-rays. Ithadpreviously beenthought thatlarge doses
on the order of 1000 rem or more were required to pro-
duce skin cancer risk. This study showed that 300 to 600
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rem to the scalp and 50 to 250 rem to the face and neck
produced a striking increase in basal cell carcinomas
(Fig. 1).
While the principaltargetorgans forradiation carcino-
genesis are now defined reasonably well, radiation
epidemiologists face a number ofnew challenging ques-
tions. What is the temporal pattern of cancer induction,
so as to estimate lifetime risk? What are the shapes of
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FIGURE 1. Cumulative incidence ofskin cancerby years since treatment
for ringworm ofthe scalp (Tinea capitis) for X-irradiated and nonir-
radiated patients.R. E. SHORE
dose-response curves for tumor induction in various or-
gans, and what are the magnitudes ofthe effects at low
doses? Are there other environmental exposures that
potentiate or inhibit radiation effects? Are there impor-
tant host-susceptibility factors and, ifso, what are they?
Data from our epidemiologic studies and others will be
used to illustrate these questions.
Probably the easiest thing to learn about the temporal
pattern ofradiogenic cancerriskis thelengthofthemini-
mum induction period. It is well documented for leuke-
miathat theminimumperiod isroughly2years, whereas
formost solidtumorsittakes 10ormoreyearsbefore any
appreciable excess risk is observed (4). In our study of
children X-irradiated for ringworm of the scalp, a long
minimum period ofover 20 years was seen for skin can-
cer induction (Fig. 1). A likely explanation for the long
periodmaybe that excess cancers do notbegin to appear
until the ages at which spontaneous cancers also become
common atthe same site-inthe case ofskin cancer dur-
ingtheir30s. Anotherfindingillustrates thispoint. In our
study ofwomen given X-ray therapy for acute postpar-
tum mastitis, mainly at ages 20 to 35, excess breast
cancers began to appear 10 to 15 years after irradiation
(5). However, among women who had been given irradi-
ation duringinfancy forallegedenlarged thymusglands,
excess breast cancers did not occur until over 30 years
after irradiation (6).
A second question about the temporal patterns ofrisk
pertains to the persistence ofrisk over the lifetime. Al-
though statistical models are a useful aid in estimating
lifetime risks, the only sure way to determine themis by
observing irradiated groups forlongperiods oftime. At
present, the follow-up periods ofmajor studies have not
been long enough to define the lifetime risks associated
with some ofthe prime cancer sites such as the breast,
thyroid, andgastrointestinal tract. The riskofleukemia
is largely defined, because leukemias appear in a wave
that tapers offto virtuallybackground levelsby about 30
years postirradiation (although the length, height, and
timing ofthe wave ofleukemia are somewhatdependent
on type of leukemia and age at irradiation) (7).
For solid tumors, one ofthe main questions in defining
lifetime risks is whether radiation multiplies the natural
age-specific risks (multiplicative riskmodel), or, instead,
adds a constant increment ofrisk at all ages(absolute ex-
cess risk model). The multiplicative risk model predicts
severaltimes asmuchlifetimeriskasthe absolute excess
model whenthe current estimates ofcancerrisks arepro-
jected out for the remaining lifetime, since most back-
ground cancerrates rise steeplywith age and amultiplier
therefore predicts larger andlargerrisks aspeople grow
older.
Analyses oftheJapanese A-bomb datahavesuggested
that for a number of cancer sites such as breast cancer,
the multiplicative riskmodelprovides abetter fit to the
datathan the absolute excess riskmodel(8,9). In contrast
to those findings, several studies ofradon exposure and
lung cancer among miners haverecentlyreported that a
multiplicative riskforlung cancertapers offatolderages
(and/or after exposure ceases; the two factors are diffi-
cult to disentangle) (10-12). In our study of thymus-
irradiated children, the temporalpattern ofthyroid can-
cer risk fit an absolute excess risk model but not a mul-
tiplicative model(13). Thus, there doesnot seemtobe any
one temporal pattern ofrisk that will apply to all types
of cancer induced by ionizing radiation.
A central question is whether small doses and/or
several small dose fractions yield as much tumorriskper
unit dose as do larger, acute exposuresforlow LET(Lin-
earEnergy Transfer)radiations suchasX-raysorgamma
rays. Manyradiobiological studies suggestthatthe effect
is smaller (per unit dose) for small exposures (14). How-
ever, our studies ofbreast cancerinwomen irradiatedfor
acutepostpartummastitis showed alinear dose-response
curve, until itbent overatthe highest doses. Most ofthe
other data available for radiogenic breast cancer support
a linear dose-response curve as well (8), although one
study appears to be an exception to this (15). Our study
ofinfants irradiated for enlarged thymusglands showed
essentially alinear dose-responsive curve forthyroid can-
cer (Fig. 2) (13). The other dose-response data available
forthyroid cancer, primarily the Japanese A-bomb study,
also support a linear relationship (16).
One concern in the radiation protection community is
the possibility that radiation effects may be potentiated
by exposure to other environmental carcinogenic cofac-
tors. Several such potentiations have been shown ex-
perimentally(17). However, there arefewhuman dataon
the subject. The best studied is the interaction ofsmok-
ing and radiation exposure with respect to lung cancer
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FIGURE 2. Thyroid cancerincidence in relation to X-ray dose in apopu-
lation given thymic irradiation in infancy and sibling controls.
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risk. Some, but not all, studies have found evidence for
potentiation by smoking (11,12,18,19).
In searchingfor potentiatingfactors in the postpartum
mastitis study, we evaluated whetherbreast cancerrisk
from radiation was potentiated by exogenous estrogens,
but found no evidence for it (20). In our scalp ringworm
study, alarge excess ofskin cancers wasfound in the ir-
radiated group as compared with a control group who
received only topical medications for the disease, indicat-
ing a clear effect due to ionizing radiation. But the data
suggested that ultraviolet radiation was an important
cofactor with the X-radiation in producing skin cancers.
The distribution ofskin cancers on the head indicated a
radiogenic effect thatwas four times as large (percm2 of
skin area per rem) on the sun-exposed face and neck as
on the hair-covered scalp (Fig. 3).
For purposes of radiation protection or of targeted
screeningofhighrisk individuals, it is important to iden-
tify host susceptibility factors. Ifcertain identifiable sub-
groups are at unusual cancer riskfollowing radiation ex-
posure, then the exposures to them should be minimized
or care taken to monitor them closely for early signs of
disease.
Withregard to radiogenic breast cancer, we havefound
two suggestions ofsubgroups withelevated risk. Women
inthe postpartummastitis studyreceivedradiation treat-
ment forbreast infections/inflammation associated with
childbirth or lactation. Even after controlling for age at
treatment, womenwho were irradiated around the time
oftheirfirst childbirth subsequently had agreaterexcess
risk(perrem)ofbreast cancerthanwomen who were ir-
radiated atthe second orlaterpregnancies. Thefindings
from other epidemiological studies indicate that the age
at first childbirth is an important risk-modifying factor
for breast cancer. Thus, our finding complements the
other findings in indicating that the first childbirth is
somehowbiologically important in definingbreast cancer
risk. The study also showed that irradiated women who
developed benign breast disease (usually subsequent to
the radiation treatment) were at veryhighriskforbreast
cancer. This suggests they shouldbe carefully monitored
for incipient breast cancers.
As another example, in the scalp ringworm X-ray
study, sensitivity to ultraviolet exposure appears to be
an important susceptibility factor for radiation-induced
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FIGURE 3. Locations of skin cancers and skin doses in rads among pa-
tientsgiven X-raytherapy forringworm ofthe scalp (Tinea capitis).
skin cancer, forno skin cancers were seen amongthe 25%
of the irradiated group who were black. Furthermore,
questionnaire information on complexionfactors showed
that light-skinned persons who freckle or sunburn easily
had the greatest excess ofradiation-induced skin cancer.
The last 40 years ofradiation epidemiology have pro-
vided a strong base of fundamental information about
radiation risks, but many interesting and challenging
questions remain. It is to be hoped that in the next 40
years we will be able to apply the principles and tech-
niques ofcancer biology and radiobiology to produce or
confirm newbiological insights. Theweddingofbiochem-
ical and molecular approaches to field studies may help
define groups who are at very high risk of radiation-
induced cancer and will no doubt increase our under-
standing of human cancer.
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